Business
-
May 19 2026The $1.1 Billion Paradox: Inside Emcure’s High-Stakes Legal Warfare, US FDA Scrutiny, and Leadership Exodus
An executive ousting, an entire dermatology unit in freefall, a…
Read more -
May 18 2026Why Healthcare in India Needs Urgent Attention?
Healthcare is not a privilege—it is a fundamental right. Yet…
Read more -
May 13 2026Vyome Seals Strategic Pact With Impetis Biosciences, Unlocking a ~$57 Billion Market Horizon
Vyome Partners With Impetis, a TATA Enterprise, to In‑License Next‑Generation…
Read more -
May 11 2026NCLT Hyderabad Clears Resolution Plan: Beaufond Industries to Acquire Kobo Biotech as Going Concern
Landmark approval under IBC, 2016 paves way for Beaufond Industries…
Read more -
Apr 26 2026Beaufond Plc Charts European Course: Advanced Negotiations Under Way for Strategic API Supply Alliance with Netherlands Pharmaceutical Group
Beaufond PLC’s bold expansion into the Netherlands signals a new…
Read more -
Apr 21 2026The Architects Of Aesthetics: How India’s Iconic Visionaries are Redefining the Global Skincare Map
The Architects Of Aesthetics: How India’s Iconic Visionaries are Redefining…
Read more -
Apr 15 2026MSN Labs Disrupts Diabetes Care with SEMABEST: India’s First Fully Integrated Semaglutide Follows Patent Expiry
From API to Pen: MSN Laboratories Challenges Global Giants with…
Read more -
Apr 04 2026Trump’s Tariff Gambit: Pharma & Metals in the Crossfire of Global Trade
Executive Orders That Redefine Trade Boundaries US President Donald Trump…
Read more -
Apr 01 2026Ethical Marketing Under Watch: NPPA & MCI Crack Down
From inducements to integrity: Can India’s pharma industry rebuild trust…
Read more -
Apr 01 2026Vyome Delivers Breakthrough 2025 Performance, Sets Stage for Next Growth Chapter
Vyome is building the world’s premier platform spanning the US-India…
Read more
